EPIDEMIOLOGY AND RISK FACTOR OF VENOUS THROMBOSIS IN CHILDREN
11:00-13:00 |
PARALLEL SESSION III: Epidemiology and risk factors of venous thrombosis in children
|
Chairpersons |
U. Nowak-Göttl, Germany
H. Van Ommen, Netherlands
|
11:00 |
State of the Art:
Epidemiology and risk factors of venous thromboembolism in children
H. Van Ommen, Netherlands
|
11:20 |
Debate: Should infants with perinatal thrombosis be screened for thrombophilia and treated by anticoagulants?
Yes: U. Nowak-Göttl, Germany
No: S. Revel-Vilk, Israel
Discussion
|
12:05 |
Debate: Is there a role for primary anticoagulant prophylaxis in children with acute lymphocytic leukemia?
Yes: U. Nowak-Göttl, Germany
No: H. Van Ommen, Netherlands
Discussion
|
12:50 |
Oral Presentation: CLINICAL AND LABORATORY CHARACTERISTICS OF CHILDREN WITH VENOUS THROMBOEMBOLISM AND PROTEIN C-DEFICIENCY: AN OBSERVATIONAL ISRAELI-GERMAN COHORT STUDY V. Limperger, Germany
|
13:00 |
Lunch break and poster viewing
|
HEMOPHILIA CARE: CURRENT GUIDELINES & APPLICATIONS OF NEW FACTOR CONCENTRATES
14:00-16:00 |
PARALLEL SESSION IV: Hemophilia care: Current guidelines and applications of new factor concentrates
|
Chairpersons |
E. Santagostino, Italy
K. Fischer, Netherlands
|
14:00 |
State of the Art:
Hemophilia care - current guidelines and applications of new factor concentrates K. Fischer, Netherlands
|
14:20 |
Debate: Prophylaxis for children with hemophilia should start early or after joint bleed? Is low dose regimen preferable to standard dose?
Early start and frequent dosing: R. Ljung, Sweden
Lower doeses: E. Santagostino, Italy
Discussion
|
15:10 |
Debate: Should we screen children for coagulopathies prior to surgery?
No - not always: C. Bidlingmaier, Germany
Yes - most of the time: S. Revel-Vilk, Israel
Discussion
|
SATURDAY, NOVEMBER 1, 2014
HEPARINS, WARFARIN & NEW ANTICOAGULANTS FOR PEDIATRIC VENOUS THROMBOSIS
10:30-12:30 |
PARALLEL SESSION VIII: Heparins, warfarin and new anticoagulants for pediatric venous thrombosis
|
Chairpersons |
C. Bidlingmaier, Germany
I. Martinelli, Italy
|
10:30 |
State of the Art:
Heparins and warfarin for pediatric venous thrombosis: Current recommendations C. Bidlingmaier, Germany
|
10:50 |
Debate: New oral anticoagulants in children: should they be prescribed for special (off label) situations?
Yes: I. Martinelli, Italy
No: A.D. Michelson, USA Discussion
|
11:35 |
Debate: Antiphospholipid syndrome in children - should similar diagnostic criteria be applied?
Yes: V. Pengo, Italy
No: T. Strauss, Israel
Discussion
|
12:20 |
Oral Presentation: IS INHERITED THROMBOPHILIA TESTING JUSTIFIED IN CHILDREN WITH PERINATAL ARTERIAL ISCHEMIC STROKE? D. Coen Herak, Croatia
|
12:30 |
Lunch break and poster viewing
|